CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- 4 Derivatives Options or other derivatives
- 4 Open-market buy EVP and CFO bought 33,333 shares at $6.00 ($199,998)
- 4 Open-market buy Chief Accounting Officer bought 10,000 shares at $6.00 ($60,000)
- 4 Open-market buy Director bought 1,620,833 shares at $6.00 ($9,724,998)
- 4 Open-market buy 10% owner bought 1,620,833 shares at $6.00 ($9,724,998)
- 4 Open-market buy Director bought 1,620,833 shares at $6.00 ($9,724,998)
- 4 Open-market buy Chief Business Officer bought 8,333 shares at $6.00 ($49,998)
- 4 Open-market buy Director bought 3,333 shares at $6.00 ($19,998)
- 4 Open-market buy Director bought 737,500 shares at $6.00 ($4,425,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 737,500 shares at $6.00 ($4,425,000)
- 4 Open-market buy President and CEO bought 41,667 shares at $6.00 ($250,002)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 14 · 264 filings